Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants.
about
Surgical and non-surgical management for intussusception in childrenRemoving the age restrictions for rotavirus vaccination: a benefit-risk modeling analysisThe Pioneering Role of the Vaccine Safety Datalink Project (VSD) to Advance Collaborative Research and Distributed Data NetworksSustaining Vaccine Confidence in the 21st CenturyDeaths following vaccination: What does the evidence show?Risk of Intussusception After Rotavirus VaccinationBaseline incidence of intussusception in early childhood before rotavirus vaccine introduction, the Netherlands, January 2008 to December 2012Incidence and risk factors for intussusception among children in northern Israel from 1992 to 2009: a retrospective study.Targeted rotavirus vaccination of high-risk infants; a low cost and highly cost-effective alternative to universal vaccination.Childhood intussusception: a literature reviewEvaluation of the Intussusception Risk after Pentavalent Rotavirus Vaccination in Finnish InfantsDemographic characteristics of members of the Vaccine Safety Datalink (VSD): A comparison with the United States population.New insights into rotavirus vaccines.Rotavirus vaccination and intussusception - Science, surveillance, and safety: A review of evidence and recommendations for future research priorities in low and middle income countries.Rectal Bleeding and Abdominal Pain Following Vaccination in a 4-Month-Old Infant.Relationship between Pentavalent Rotavirus Vaccine and Intussusception: A Retrospective Study at a Single Center in KoreaImpact of rotavirus vaccines on rotavirus disease.Diagnosis, management, and prevention of rotavirus gastroenteritis in children.Rotavirus vaccination: a risk factor for intussusception?Diversity of rotavirus strains circulating in children under 5 years of age admitted to hospital for acute gastroenteritis in Morocco, June 2006 to May 2009.A vaccine study design selection framework for the postlicensure rapid immunization safety monitoring program.Does preventing rotavirus infections through vaccination also protect against naturally occurring intussusception over time?Intussusception risk increased after rotavirus vaccination but outweighed by benefits.Treatment and prevention of rotavirus infection in children.Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program.Editorial commentary: intussusception and rotavirus vaccination--balancing risk against benefit.Rotavirus virus-like particles (RV-VLPs) vaccines: An update.Potential intussusception risk versus benefits of rotavirus vaccination in the United States.Safety study of live, oral human rotavirus vaccine: A cohort study in United States health insurance plans.Gamma-irradiated rotavirus: A possible whole virus inactivated vaccine.
P2860
Q24246078-B906AFB6-571F-4580-B370-3E710B1C8749Q28484524-1C6E2356-05E3-471C-9B0F-267A5D18E7A9Q28602789-DE01888E-7903-4009-A50E-29A69183C52BQ28647427-09CF9E59-4386-482D-9257-47BEE75023BEQ33165769-F56B64BA-F50A-4C0B-A5D6-12667D3433EDQ33654119-0FC7688B-0907-4F7B-898D-EA710B5F83FEQ33851647-C45D03D7-571C-450A-BB68-A0EADAA888C9Q34538651-3CB59F36-E327-45A0-94EF-E510E9E7DD0DQ34690736-5646ED52-39D4-4ACC-B681-CF6A22F7C78CQ34872716-2D53B0DB-62BA-4605-BD28-318BC0FA2340Q35947992-B4AAECA2-69F9-482D-9F22-42A7F1F3F9C3Q35991578-E187E24F-0D52-4C85-83AE-5E92E03EC58AQ36552854-F383D026-446F-48E2-B34A-8374271FF06BQ37375904-3523F2E2-E985-43B4-8408-855A9E39806DQ37598089-6AC38170-E9ED-46A2-BF0A-F611766C3222Q37723321-A3812E97-3873-49BF-B069-8696E4C5A45FQ38018979-290049B8-1FF0-4BE4-9A7B-D63F5CB57A31Q38174842-A99C0CB0-612A-4932-B01B-599FD42AA6D6Q38182398-E39B1E08-BFD9-40D9-8055-D87291993C8FQ38903522-6BB7BA43-6E0D-41C2-A719-3BC7360EA329Q39029570-50BAB70B-788C-4E30-8402-B95B87BD6717Q41728495-73EE1A4A-BC71-4DA3-A723-3E26106CCA53Q42220576-B8585959-29B1-4B2F-B3F9-14002C7C0AA1Q42269528-523AF71F-F5C1-4768-949C-58A4207A96C1Q44106887-80E1AC5F-57CE-4070-9AF8-3D6045788328Q45260893-5E7A1F53-7DFF-4356-8967-40B01AA36863Q45326050-E2A1E647-89E5-49DD-B476-E130860CE29FQ45822805-C174F29B-D3DD-4E96-B624-103D80EBE43FQ52658436-86BD06F5-79D2-423A-B031-32D77B70F0C2Q55405177-03A3D7ED-3B72-47C0-97F2-843F5CE329CB
P2860
Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Risk of intussusception follow ...... tavirus vaccine in US infants.
@en
Risk of intussusception follow ...... tavirus vaccine in US infants.
@nl
type
label
Risk of intussusception follow ...... tavirus vaccine in US infants.
@en
Risk of intussusception follow ...... tavirus vaccine in US infants.
@nl
prefLabel
Risk of intussusception follow ...... tavirus vaccine in US infants.
@en
Risk of intussusception follow ...... tavirus vaccine in US infants.
@nl
P2093
P50
P356
P1476
Risk of intussusception follow ...... tavirus vaccine in US infants.
@en
P2093
Eric Weintraub
Irene M Shui
James Baggs
Jason M Glanz
Manish Patel
Melisa Rett
Simon J Hambidge
P304
P356
10.1001/JAMA.2012.97
P407
P577
2012-02-01T00:00:00Z